Compare Centrus Energy Corp (LEU) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centrus Energy Corp vs Novo Nordisk A/S — how do they compare? Centrus Energy Corp trades at $170.5 (market cap $3.08B), while Novo Nordisk A/S trades at $49.35 (market cap $220.53B). The key difference: Novo Nordisk A/S is far larger — about 71.6× Centrus Energy Corp's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals.
| LEU | NVO | |
|---|---|---|
Market Cap | $3.08B | $220.53B |
Sector | Energy | Health |
52-Week High | $436.00 | $71.70 |
52-Week Low | $146.61 | $35.29 |
Enterprise Value | $2.39B | $239.49B |
Dividend Yield | — | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
